ORC6

Across TCGA pan-cancer cohorts, ORC6 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ORC6 data layer compared with 28 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher ORC6 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ORC6 expression acts as an unfavorable survival marker.

BRCA and UCEC are the cancer types where ORC6 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	II,III,IV	0.027	0.958	<.001	32	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ORC6–BRCA (OS)

Open the BRCA breakdown →